Dr. Lucy Jessop:

On the vaccines we have in the EU and equivalent vaccines, for example, the AstraZeneca vaccine being used in India, there is published data relating to their effectiveness. The Sinopharm vaccine is not seen to be as effective as some of the other vaccines we are using in Europe. The matter the Deputy raised may well be related to that. I am sure, as with all these things, these matters are being reviewed with respect to which of the vaccines should be taken into account in the context of mandatory quarantine or people being able to quarantine at home instead.